Rite Aid Revenue 2010-2022 | RAD

Rite Aid revenue from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Rite Aid Annual Revenue
(Millions of US $)
2022 $24,568
2021 $24,043
2020 $21,928
2019 $21,640
2018 $21,529
2017 $22,928
2016 $20,770
2015 $26,528
2014 $25,526
2013 $25,392
2012 $26,121
2011 $25,215
2010 $25,669
2009 $26,289
Rite Aid Quarterly Revenue
(Millions of US $)
2022-05-31 $6,015
2022-02-28 $6,065
2021-11-30 $6,229
2021-08-31 $6,113
2021-05-31 $6,161
2021-02-28 $5,917
2020-11-30 $6,117
2020-08-31 $5,982
2020-05-31 $6,027
2020-02-29 $5,727
2019-11-30 $5,462
2019-08-31 $5,366
2019-05-31 $5,373
2019-02-28 $5,380
2018-11-30 $5,450
2018-08-31 $5,421
2018-05-31 $5,388
2018-02-28 $5,394
2017-11-30 $5,353
2017-08-31 $5,345
2017-05-31 $5,437
2017-02-28 $1,044
2016-11-30 $5,669
2016-08-31 $8,030
2016-05-31 $8,184
2016-02-29 $8,270
2015-11-30 $8,154
2015-08-31 $7,665
2015-05-31 $6,648
2015-02-28 $6,848
2014-11-30 $6,692
2014-08-31 $6,523
2014-05-31 $6,466
2014-02-28 $6,597
2013-11-30 $6,358
2013-08-31 $6,278
2013-05-31 $6,293
2013-02-28 $6,455
2012-11-30 $6,238
2012-08-31 $6,231
2012-05-31 $6,468
2012-02-29 $7,147
2011-11-30 $6,313
2011-08-31 $6,271
2011-05-31 $6,391
2011-02-28 $6,456
2010-11-30 $6,202
2010-08-31 $6,162
2010-05-31 $6,394
2010-02-28 $6,464
2009-11-30 $6,352
2009-08-31 $6,322
2009-05-31 $6,531
2009-02-28 $6,708
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $0.615B $24.568B
Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $139.672B 12.41
Herbalife (HLF) United States $3.142B 7.81
GNC Holdings (GNC) United States $0.000B 0.00